185 related articles for article (PubMed ID: 18548482)
1. Randomized clinical trial to assess the efficacy of ulinastatin for postoperative pancreatitis following pancreaticoduodenectomy.
Uemura K; Murakami Y; Hayashidani Y; Sudo T; Hashimoto Y; Ohge H; Sueda T
J Surg Oncol; 2008 Oct; 98(5):309-13. PubMed ID: 18548482
[TBL] [Abstract][Full Text] [Related]
2. Prospective, randomized, double-blind, placebo-controlled trial of ulinastatin for prevention of hyperenzymemia after double balloon endoscopy via the antegrade approach.
Itaba S; Nakamura K; Aso A; Tokunaga S; Akiho H; Ihara E; Iboshi Y; Iwasa T; Akahoshi K; Ito T; Takayanagi R
Dig Endosc; 2013 Jul; 25(4):421-7. PubMed ID: 23368820
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of intravenous ulinastatin versus placebo along with standard supportive care in subjects with mild or severe acute pancreatitis.
Abraham P; Rodriques J; Moulick N; Dharap S; Chafekar N; Verma PK; Agrawal A; Prabhakar B; Basavaraj A; Shah A; Chaphekar AP; Biswal UC; Malhan ST; Bakshi G
J Assoc Physicians India; 2013 Aug; 61(8):535-8. PubMed ID: 24818336
[TBL] [Abstract][Full Text] [Related]
4. Ulinastatin shows preventive effect on post-endoscopic retrograde cholangiopancreatography pancreatitis in a multicenter prospective randomized study.
Fujishiro H; Adachi K; Imaoka T; Hashimoto T; Kohge N; Moriyama N; Suetsugu H; Kawashima K; Komazawa Y; Ishimura N; Ishihara S; Amano Y; Kinoshita Y
J Gastroenterol Hepatol; 2006 Jun; 21(6):1065-9. PubMed ID: 16724996
[TBL] [Abstract][Full Text] [Related]
5. Preventive effects of ulinastatin on complications related to pancreaticoduodenectomy: A Consort-prospective, randomized, double-blind, placebo-controlled trial.
Zhang H; Tan C; Wang X; Kang D; Chen Y; Xiong J; Tian B; Li K; Hu W; Chen X; Ke N; Li A; Liu X
Medicine (Baltimore); 2016 Jun; 95(24):e3731. PubMed ID: 27310952
[TBL] [Abstract][Full Text] [Related]
6. Preventive effects of ulinastatin on post-endoscopic retrograde cholangiopancreatography pancreatitis in high-risk patients: a prospective, randomized, placebo-controlled trial.
Yoo JW; Ryu JK; Lee SH; Woo SM; Park JK; Yoon WJ; Lee JK; Lee KH; Hwang JH; Kim YT; Yoon YB
Pancreas; 2008 Nov; 37(4):366-70. PubMed ID: 18953247
[TBL] [Abstract][Full Text] [Related]
7. Ulinastatin for pancreatitis after endoscopic retrograde cholangiopancreatography: a randomized, controlled trial.
Tsujino T; Komatsu Y; Isayama H; Hirano K; Sasahira N; Yamamoto N; Toda N; Ito Y; Nakai Y; Tada M; Matsumura M; Yoshida H; Kawabe T; Shiratori Y; Omata M
Clin Gastroenterol Hepatol; 2005 Apr; 3(4):376-83. PubMed ID: 15822043
[TBL] [Abstract][Full Text] [Related]
8. Role of ulinastatin in preventing post-endoscopic retrograde cholangiopancreatography pancreatitis: the Emperor's New Clothes or Aladdin's Magic Lamp?
Chen S; Shi H; Zou X; Luo H
Pancreas; 2010 Nov; 39(8):1231-7. PubMed ID: 20531245
[TBL] [Abstract][Full Text] [Related]
9. The risk for immediate postoperative complications after pancreaticoduodenectomy is increased by high frequency of acinar cells and decreased by prevalent fibrosis of the cut edge of pancreas.
Laaninen M; Bläuer M; Vasama K; Jin H; Räty S; Sand J; Nordback I; Laukkarinen J
Pancreas; 2012 Aug; 41(6):957-61. PubMed ID: 22699198
[TBL] [Abstract][Full Text] [Related]
10. The results of the Tokyo trial of prevention of post-ERCP pancreatitis with risperidone (Tokyo P3R): a multicenter, randomized, phase II, non-placebo-controlled trial.
Tsujino T; Isayama H; Nakai Y; Ito Y; Togawa O; Toda N; Arizumi T; Kogure H; Yamamoto K; Mizuno S; Yashima Y; Yagioka H; Sasaki T; Matsubara S; Yamamoto N; Hirano K; Sasahira N; Tada M; Koike K
J Gastroenterol; 2013 Aug; 48(8):982-8. PubMed ID: 23090004
[TBL] [Abstract][Full Text] [Related]
11. Effect of Somatostatin, Ulinastatin and Gabexate on the Treatment of Severe Acute Pancreatitis.
Wang G; Liu Y; Zhou SF; Qiu P; Xu L; Wen P; Wen J; Xiao X
Am J Med Sci; 2016 May; 351(5):506-12. PubMed ID: 27140710
[TBL] [Abstract][Full Text] [Related]
12. Comparison between ulinastatin and nafamostat for prevention of post-endoscopic retrograde cholangiopancreatography complications: a prospective, randomized trial.
Park JY; Jeon TJ; Hwang MW; Sinn DH; Oh TH; Shin WC; Choi WC
Pancreatology; 2014; 14(4):263-7. PubMed ID: 25062874
[TBL] [Abstract][Full Text] [Related]
13. Acinar cell density at the pancreatic resection margin is associated with post-pancreatectomy pancreatitis and the development of postoperative pancreatic fistula.
Nahm CB; Brown KM; Townend PJ; Colvin E; Howell VM; Gill AJ; Connor S; Samra JS; Mittal A
HPB (Oxford); 2018 May; 20(5):432-440. PubMed ID: 29307511
[TBL] [Abstract][Full Text] [Related]
14. Comparison between ulinastatin and gabexate mesylate for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a prospective, randomized trial.
Ueki T; Otani K; Kawamoto K; Shimizu A; Fujimura N; Sakaguchi S; Matsui T
J Gastroenterol; 2007 Feb; 42(2):161-7. PubMed ID: 17351806
[TBL] [Abstract][Full Text] [Related]
15. Elevation of urine trypsinogen 2 is an independent risk factor for pancreatic fistula after pancreaticoduodenectomy.
Uemura K; Murakami Y; Sudo T; Hashimoto Y; Nakashima A; Yamaoka E; Sueda T
Pancreas; 2012 Aug; 41(6):876-81. PubMed ID: 22357509
[TBL] [Abstract][Full Text] [Related]
16. Use of the urinary trypsinogen-2 dip stick test in early diagnosis of pancreatitis after endoscopic retrograde cholangiopancreatography.
Sankaralingam S; Wesen C; Barawi M; Galera R; Lloyd L
Surg Endosc; 2007 Aug; 21(8):1312-5. PubMed ID: 17332967
[TBL] [Abstract][Full Text] [Related]
17. [Clinical value of the early use of ulinastatin in patients with moderately severe or severe acute pancreatitis].
Wang J; Jin J; Huang J; Li DR; Hao Y; Kong JD; Chu ZY; Fu JH; Huang F
Zhonghua Yi Xue Za Zhi; 2017 Apr; 97(16):1252-1255. PubMed ID: 28441856
[No Abstract] [Full Text] [Related]
18. A randomized control study to investigate the application of Ulinastatin-containing contrast medium to prevent post-ERCP pancreatitis.
Wang J; Su J; Lu Y; Zhou H; Gong B
Hepatogastroenterology; 2014; 61(136):2391-4. PubMed ID: 25699389
[TBL] [Abstract][Full Text] [Related]
19. Role of Ulinastatin, a trypsin inhibitor, in severe acute pancreatitis in critical care setting: A retrospective analysis.
Lagoo JY; D'Souza MC; Kartha A; Kutappa AM
J Crit Care; 2018 Jun; 45():27-32. PubMed ID: 29413719
[TBL] [Abstract][Full Text] [Related]
20. Rapid urinary trypsinogen-2 test strip in the diagnosis of pancreatitis after endoscopic retrograde cholangiopancreatography.
Tseng CW; Chen CC; Lin SZ; Chang FY; Lin HC; Lee SD
Pancreas; 2011 Nov; 40(8):1211-4. PubMed ID: 21946810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
